QuidelOrtho (QDEL) director receives 15,532 restricted stock units as equity award
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Huennekens R Scott reported acquisition or exercise transactions in this Form 4 filing.
QuidelOrtho Corp director R. Scott Huennekens received a grant of restricted stock units as equity compensation. He was awarded 15,532 restricted stock units representing the right to receive an equal number of shares of QuidelOrtho common stock. These restricted stock units will vest on June 25, 2027, and following the grant he holds 15,532 such units directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Huennekens R Scott
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units (Equity Grant) | 15,532 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Units (Equity Grant) — 15,532 shares (Direct, null)
Footnotes (1)
- Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. The restricted stock units will vest on June 25, 2027.
Key Figures
RSUs granted: 15,532 units
RSU exercise price: $0.00 per unit
RSUs after transaction: 15,532 units
+2 more
5 metrics
RSUs granted
15,532 units
Equity grant on June 25, 2026
RSU exercise price
$0.00 per unit
Restricted stock unit grant terms
RSUs after transaction
15,532 units
Total restricted stock units held directly after grant
Vesting date
June 25, 2027
Restricted stock units vesting schedule
Underlying common shares
15,532 shares
Each RSU represents one share of common stock
Key Terms
Restricted Stock Units, grant/award acquisition, vest, underlying security
4 terms
Restricted Stock Units financial
"He was awarded 15,532 restricted stock units representing the right to receive"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
grant/award acquisition financial
"The transaction is coded as a grant or award acquisition, reflecting compensation"
vest financial
"The restricted stock units will vest on June 25, 2027."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
underlying security financial
"Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock as the underlying security."
FAQ
What did QuidelOrtho (QDEL) director R. Scott Huennekens report on this Form 4?
He reported receiving a grant of 15,532 restricted stock units as equity compensation. Each unit is tied to one share of QuidelOrtho common stock and vests on June 25, 2027, increasing his direct equity-based holdings.
How many restricted stock units did Huennekens acquire in the QuidelOrtho (QDEL) filing?
He acquired 15,532 restricted stock units in this transaction. These units represent potential future shares of QuidelOrtho common stock and bring his total restricted stock unit holdings reported in this filing to 15,532 units held directly.
When do the newly granted QuidelOrtho (QDEL) restricted stock units vest?
The restricted stock units vest on June 25, 2027. Vesting means that on that date, subject to any applicable conditions, each unit is expected to convert into one share of QuidelOrtho common stock for the reporting person.
What does each QuidelOrtho (QDEL) restricted stock unit represent in this Form 4?
Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. The units are a form of equity compensation that typically convert into shares upon vesting, aligning the director’s interests with shareholders over time.